| scholarly article | Q13442814 |
| P2093 | author name string | Edward Roberts | |
| Hugh Rosen | |||
| John R Teijaro | |||
| Michael B A Oldstone | |||
| Stuart Cahalan | |||
| Fiona Scott | |||
| Kevin B Walsh | |||
| Robert Peach | |||
| Esther Martinborough | |||
| Daniel M Fremgen | |||
| P2860 | cites work | Sphingosine 1-phosphate receptor signaling | Q34949383 |
| Sphingosine 1-phosphate pathway therapeutics: a lipid ligand-receptor paradigm | Q35206936 | ||
| Type 1 interferons and the virus-host relationship: a lesson in détente . | Q36475884 | ||
| Hantavirus cardiopulmonary syndrome: immune response and pathogenesis. | Q36515697 | ||
| Tipping the gatekeeper: S1P regulation of endothelial barrier function | Q36727643 | ||
| Local not systemic modulation of dendritic cell S1P receptors in lung blunts virus-specific immune responses to influenza | Q36952932 | ||
| The alliance of sphingosine-1-phosphate and its receptors in immunity | Q37010807 | ||
| A critical role for the sphingosine analog AAL-R in dampening the cytokine response during influenza virus infection | Q37083628 | ||
| Interferon and cytokine responses to SARS-coronavirus infection | Q37102729 | ||
| Modulating tone: the overture of S1P receptor immunotherapeutics | Q37211268 | ||
| S1P1-selective in vivo-active agonists from high-throughput screening: off-the-shelf chemical probes of receptor interactions, signaling, and fate | Q40405662 | ||
| Symptom pathogenesis during acute influenza: interleukin-6 and other cytokine responses | Q40600935 | ||
| The cytokine storm in multiple sclerosis | Q41734496 | ||
| Monoclonal antibody to the murine type 3 complement receptor inhibits adhesion of myelomonocytic cells in vitro and inflammatory cell recruitment in vivo | Q41905685 | ||
| Lethal influenza virus infection in macaques is associated with early dysregulation of inflammatory related genes | Q21559413 | ||
| Actions of a picomolar short-acting S1P₁ agonist in S1P₁-eGFP knock-in mice | Q24609856 | ||
| Full pharmacological efficacy of a novel S1P1 agonist that does not require S1P-like headgroup interactions | Q24646942 | ||
| Induction of a Striking Systemic Cytokine Cascade prior to Peak Viremia in Acute Human Immunodeficiency Virus Type 1 Infection, in Contrast to More Modest and Delayed Responses in Acute Hepatitis B and C Virus Infections | Q27488278 | ||
| Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia | Q28262914 | ||
| Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus | Q28283850 | ||
| Contrasting effects of CCR5 and CCR2 deficiency in the pulmonary inflammatory response to influenza A virus | Q28589623 | ||
| In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses | Q29619174 | ||
| Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus. | Q30343761 | ||
| A question of self-preservation: immunopathology in influenza virus infection. | Q30359144 | ||
| Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza. | Q30383368 | ||
| Influenza vaccination: lessons learned from the pandemic (H1N1) 2009 influenza outbreak. | Q30390413 | ||
| Virulence determinants of pandemic influenza viruses | Q30398168 | ||
| Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense | Q30448808 | ||
| Cytokine kinetics and other host factors in response to pneumococcal pulmonary infection in mice | Q33501805 | ||
| Influenza virus receptor specificity: disease and transmission | Q33745072 | ||
| Phosphorylation and action of the immunomodulator FTY720 inhibits vascular endothelial cell growth factor-induced vascular permeability. | Q34227743 | ||
| Cytokine-dependent but acquired immunity-independent arthritis caused by DNA escaped from degradation | Q34320329 | ||
| Enhancement of capillary leakage and restoration of lymphocyte egress by a chiral S1P1 antagonist in vivo. | Q34546048 | ||
| Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis | Q34624835 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| P304 | page(s) | 980-991 | |
| P577 | publication date | 2011-09-01 | |
| P1433 | published in | Cell | Q655814 |
| P1476 | title | Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection | |
| P478 | volume | 146 |
| Q28069689 | A Dormant Microbial Component in the Development of Preeclampsia |
| Q38074494 | A brief primer on microRNAs and their roles in angiogenesis |
| Q40449457 | A new shield for a cytokine storm. |
| Q47679381 | A review of bioanalytical quantitative methods for selected sphingosine 1-phosphate receptor modulators |
| Q34311835 | A single E627K mutation in the PB2 protein of H9N2 avian influenza virus increases virulence by inducing higher glucocorticoids (GCs) level |
| Q37205972 | A sphingosine 1-phosphate receptor 2 selective allosteric agonist. |
| Q46225129 | A sphingosine-1-phosphate receptor 1 agonist inhibits tertiary lymphoid tissue reactivation and hypersensitivity in the lung |
| Q37148404 | A systems analysis identifies a feedforward inflammatory circuit leading to lethal influenza infection |
| Q35640967 | A(H7N9) virus results in early induction of proinflammatory cytokine responses in both human lung epithelial and endothelial cells and shows increased human adaptation compared with avian H5N1 virus |
| Q89838043 | AMP-Activated Protein Kinase Restricts Zika Virus Replication in Endothelial Cells by Potentiating Innate Antiviral Responses and Inhibiting Glycolysis |
| Q26753030 | Aberrant coagulation causes a hyper-inflammatory response in severe influenza pneumonia |
| Q92138204 | Advances in COVID-19: the virus, the pathogenesis, and evidence-based control and therapeutic strategies |
| Q26829985 | Advancing Biological Understanding and Therapeutics Discovery with Small-Molecule Probes |
| Q58604755 | An update on sphingosine-1-phosphate receptor 1 modulators |
| Q33887756 | Animal model of respiratory syncytial virus: CD8+ T cells cause a cytokine storm that is chemically tractable by sphingosine-1-phosphate 1 receptor agonist therapy |
| Q37482511 | Annexin A6-balanced late endosomal cholesterol controls influenza A replication and propagation |
| Q40844952 | Anti-inflammatory effects of indirubin derivatives on influenza A virus-infected human pulmonary microvascular endothelial cells |
| Q36729601 | Anti-inflammatory role of PGD2 in acute lung inflammation and therapeutic application of its signal enhancement |
| Q36966984 | Antigen-activated dendritic cells ameliorate influenza A infections |
| Q37743174 | Antiviral activity of chlorogenic acid against influenza A (H1N1/H3N2) virus and its inhibition of neuraminidase |
| Q28394994 | Antiviral regulation in porcine monocytic cells at different activation states |
| Q36633504 | Apolipoprotein M--a new biomarker in sepsis |
| Q92188823 | Arid5a Regulation and the Roles of Arid5a in the Inflammatory Response and Disease |
| Q27342989 | Asparagine endopeptidase controls anti-influenza virus immune responses through TLR7 activation |
| Q97518993 | Battling COVID-19 Pandemic: Sphingosine-1-Phosphate Analogs as an Adjunctive Therapy? |
| Q38204273 | Blood, sphingosine-1-phosphate and lymphocyte migration dynamics in the spleen. |
| Q38964762 | C-X-C motif chemokine 10 in non-alcoholic steatohepatitis: role as a pro-inflammatory factor and clinical implication |
| Q37730623 | CD11b activation suppresses TLR-dependent inflammation and autoimmunity in systemic lupus erythematosus |
| Q95321982 | COVID-19: the vasculature unleashed |
| Q91931325 | Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)? |
| Q55402793 | Cardiogenic Shock: A Rare Complication of Influenza. |
| Q33584810 | Characterization of the anti-influenza activity of the Chinese herbal plant Paeonia lactiflora |
| Q40348056 | Chemerin has a protective role in hepatocellular carcinoma by inhibiting the expression of IL-6 and GM-CSF and MDSC accumulation |
| Q38204272 | Chemical and genetic tools to explore S1P biology |
| Q30354070 | Closely related influenza viruses induce contrasting respiratory tract immunopathology |
| Q64115941 | Combination of sphingosine-1-phosphate receptor 1 (S1PR1) agonist and antiviral drug: a potential therapy against pathogenic influenza virus |
| Q30420448 | Comparison of temporal and spatial dynamics of seasonal H3N2, pandemic H1N1 and highly pathogenic avian influenza H5N1 virus infections in ferrets |
| Q30393767 | Constitutively Expressed IFITM3 Protein in Human Endothelial Cells Poses an Early Infection Block to Human Influenza Viruses |
| Q36162671 | Context-specific roles for paracrine IL-6 in lymphomagenesis |
| Q95274045 | Could pulmonary arterial hypertension patients be at a lower risk from severe COVID-19? |
| Q34157497 | Cross-talk between Staphylococcus aureus leukocidins-intoxicated macrophages and lung epithelial cells triggers chemokine secretion in an inflammasome-dependent manner. |
| Q39337284 | Cytokine storm and sepsis disease pathogenesis |
| Q94491217 | Cytokine storm intervention in the early stages of COVID-19 pneumonia |
| Q38204274 | Cytokine storm plays a direct role in the morbidity and mortality from influenza virus infection and is chemically treatable with a single sphingosine-1-phosphate agonist molecule |
| Q44277427 | Cytokine storms in infectious diseases |
| Q60046851 | Cytokine-Mediated Tissue Injury in Non-human Primate Models of Viral Infections |
| Q36206313 | Decreased serum concentrations of sphingosine-1-phosphate in sepsis |
| Q36280060 | Dengue Virus-Induced Inflammation of the Endothelium and the Potential Roles of Sphingosine Kinase-1 and MicroRNAs. |
| Q36487304 | Dietary abscisic acid ameliorates influenza-virus-associated disease and pulmonary immunopathology through a PPARγ-dependent mechanism |
| Q64062650 | Differential modulation of pulmonary caspases: Is this the key to Ureaplasma-driven chronic inflammation? |
| Q38065392 | Dissecting influenza virus pathogenesis uncovers a novel chemical approach to combat the infection |
| Q38193705 | Dynamics of pulmonary endothelial barrier function in acute inflammation: mechanisms and therapeutic perspectives |
| Q37689400 | Dynamin 2-dependent endocytosis is required for sustained S1PR1 signaling |
| Q59358581 | EMAPII Monoclonal Antibody Ameliorates Influenza A Virus-Induced Lung Injury |
| Q28728791 | Effect of adjuvants on responses to skin immunization by microneedles coated with influenza subunit vaccine |
| Q92117658 | Elevated troponin in patients with Coronavirus Disease 2019 (COVID-19): possible mechanisms |
| Q28085230 | Emerging Infections of CNS: Avian Influenza A Virus, Rift Valley Fever Virus and Human Parechovirus |
| Q39168387 | Emerging avian influenza infections: Current understanding of innate immune response and molecular pathogenesis |
| Q35535621 | Emerging biology of sphingosine-1-phosphate: its role in pathogenesis and therapy |
| Q38122283 | Emerging therapeutic strategies to prevent infection-related microvascular endothelial activation and dysfunction |
| Q38277249 | Endogenous and exogenous cell-based pathways for recovery from acute respiratory distress syndrome |
| Q38122282 | Endothelial activation and dysfunction in the pathogenesis of influenza A virus infection |
| Q33419868 | Endothelial cell dysfunction in viral hemorrhage and edema |
| Q37716213 | Endothelial cell tropism is a determinant of H5N1 pathogenesis in mammalian species |
| Q36086727 | Endothelial cells elicit immune-enhancing responses to dengue virus infection |
| Q26825663 | Endothelial cells in dengue hemorrhagic fever |
| Q36252688 | Endothelial cells in the eyes of an immunologist |
| Q36953507 | Endothelial peroxisomal dysfunction and impaired pexophagy promotes oxidative damage in lipopolysaccharide-induced acute kidney injury |
| Q92290922 | Evaluation of Activation and Inflammatory Activity of Myeloid Cells During Pathogenic Human Coronavirus Infection |
| Q27319771 | Evidence for a Novel Mechanism of Influenza Virus-Induced Type I Interferon Expression by a Defective RNA-Encoded Protein |
| Q40471951 | Experimental Lung Injury Reduces Krüppel-like Factor 2 to Increase Endothelial Permeability via Regulation of RAPGEF3-Rac1 Signaling. |
| Q41450597 | FPR2: A Novel Promising Target for the Treatment of Influenza |
| Q34089093 | FTY720 (s)-phosphonate preserves sphingosine 1-phosphate receptor 1 expression and exhibits superior barrier protection to FTY720 in acute lung injury |
| Q33799835 | Geldanamycin Reduces Acute Respiratory Distress Syndrome and Promotes the Survival of Mice Infected with the Highly Virulent H5N1 Influenza Virus |
| Q90629841 | Glycemic Variability in Diabetes Increases the Severity of Influenza |
| Q93166497 | H1N1 with fatal viral septicemia in a normal child: A case report |
| Q30364306 | H7N9 and other pathogenic avian influenza viruses elicit a three-pronged transcriptomic signature that is reminiscent of 1918 influenza virus and is associated with lethal outcome in mice |
| Q37361590 | H9N2 avian influenza infection altered expression pattern of sphiogosine-1-phosphate receptor 1 in BALB/c mice |
| Q91187764 | HDAC inhibitors promote intestinal epithelial regeneration via autocrine TGFβ1 signalling in inflammation |
| Q40612933 | Heat-Shock Protein gp96 Enhances T Cell Responses and Protective Potential to Bacillus Calmette-Guérin Vaccine |
| Q30366138 | Heterogeneous pathological outcomes after experimental pH1N1 influenza infection in ferrets correlate with viral replication and host immune responses in the lung. |
| Q89965395 | High Levels of miR-483-3p Are Present in Serum Exosomes Upon Infection of Mice With Highly Pathogenic Avian Influenza Virus |
| Q98224836 | High-Dose Intravenous Immunoglobulins in the Treatment of Severe Acute Viral Pneumonia: The Known Mechanisms and Clinical Effects |
| Q39187729 | Highly pathogenic influenza viruses inhibit inflammatory response in monocytes via activation of rar-related orphan receptor RORα. |
| Q52726627 | Host gene expression profiles in ferrets infected with genetically distinct henipavirus strains. |
| Q30375716 | Host genes and influenza pathogenesis in humans: an emerging paradigm. |
| Q30391411 | Human Influenza Virus Infections |
| Q39045096 | Human lung ex vivo infection models. |
| Q61450444 | Human polyomavirus BKV infection of endothelial cells results in interferon pathway induction and persistence |
| Q52599302 | IFIT1 Expression Patterns Induced by H9N2 Virus and Inactivated Viral Particle in Human Umbilical Vein Endothelial Cells and Bronchus Epithelial Cells. |
| Q49838882 | IFN and cytokine responses in ducks to genetically similar H5N1 influenza A viruses of varying pathogenicity |
| Q26825091 | Imaging S1P1 activation in vivo |
| Q40135210 | Immune Responses of Chickens Infected with Wild Bird-Origin H5N6 Avian Influenza Virus |
| Q95936505 | Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2 |
| Q92904646 | Immunological and pathological effects of vitamin E with Fetomune Plus® on chickens experimentally infected with avian influenza virus H9N2 |
| Q40113378 | Implication of sphingosine-1-phosphate signaling in diseases: molecular mechanism and therapeutic strategies |
| Q38895935 | Induction of interleukin-1 beta (IL-1β) is a critical component of lung inflammation during influenza A (H1N1) virus infection |
| Q36788220 | Inflammatory response of mast cells during influenza A virus infection is mediated by active infection and RIG-I signaling |
| Q27692695 | Inflection points in sepsis biology: from local defense to systemic organ injury |
| Q37580796 | Influenza A Viruses Replicate Productively in Mouse Mastocytoma Cells (P815) and Trigger Pro-inflammatory Cytokine and Chemokine Production through TLR3 Signaling Pathway |
| Q30357141 | Influenza A virus infections in swine: pathogenesis and diagnosis. |
| Q37218517 | Influenza SIRS with Minimal Pneumonitis |
| Q30402798 | Influenza Virus and Glycemic Variability in Diabetes: A Killer Combination? |
| Q34131746 | Influenza causes prolonged disruption of the alveolar-capillary barrier in mice unresponsive to mesenchymal stem cell therapy |
| Q34463502 | Influenza infects lung microvascular endothelium leading to microvascular leak: role of apoptosis and claudin-5. |
| Q28083505 | Influenza lung injury: mechanisms and therapeutic opportunities |
| Q38199691 | Influenza viral manipulation of sphingolipid metabolism and signaling to modulate host defense system |
| Q38292659 | Influenza virus and endothelial cells: a species specific relationship |
| Q92029965 | Influenza virus-related critical illness: pathophysiology and epidemiology |
| Q59136752 | Influenza, evolution, and the next pandemic |
| Q41401392 | Influenza-Induced Priming and Leak of Human Lung Microvascular Endothelium upon Exposure to Staphylococcus aureus |
| Q57286125 | Inhibition of autophagy and chemokine induction by sphingosine 1-phosphate receptor 1 through NF-κB signaling in human pulmonary endothelial cells infected with influenza A viruses |
| Q37428595 | Inhibition of p38 mitogen-activated protein kinase impairs influenza virus-induced primary and secondary host gene responses and protects mice from lethal H5N1 infection |
| Q33754820 | Inhibition of the inflammatory cytokine tumor necrosis factor-alpha with etanercept provides protection against lethal H1N1 influenza infection in mice |
| Q64229581 | Innate Immune Responses to Avian Influenza Viruses in Ducks and Chickens |
| Q33923354 | Innate immunity to influenza virus infection |
| Q30410415 | Interaction between innate immunity and porcine reproductive and respiratory syndrome virus |
| Q41826464 | Interleukin-1 receptor-associated kinase M-deficient mice demonstrate an improved host defense during Gram-negative pneumonia |
| Q98161951 | Interplay between SARS-CoV-2 and the type I interferon response |
| Q35804633 | Into the eye of the cytokine storm |
| Q36363186 | Intranasal treatment with poly(I•C) protects aged mice from lethal respiratory virus infections |
| Q45325330 | Investigation of antiviral state mediated by interferon-inducible transmembrane protein 1 induced by H9N2 virus and inactivated viral particle in human endothelial cells |
| Q36186133 | Involvement of the different lung compartments in the pathogenesis of pH1N1 influenza virus infection in ferrets |
| Q89339087 | Isolation and Purification of Epithelial and Endothelial Cells from Mouse Lung |
| Q46065423 | Kupffer cells and activation of endothelial TLR4 coordinate neutrophil adhesion within liver sinusoids during endotoxemia |
| Q36692797 | Lessons learned and concepts formed from study of the pathogenesis of the two negative-strand viruses lymphocytic choriomeningitis and influenza |
| Q59359537 | Lethal Influenza in Two Related Adults with Inherited GATA2 Deficiency |
| Q102211190 | Leukocyte trafficking to the lungs and beyond: lessons from influenza for COVID-19 |
| Q98727079 | Low level laser therapy as a modality to attenuate cytokine storm at multiple levels, enhance recovery, and reduce the use of ventilators in COVID-19 |
| Q30375527 | Lower Respiratory Tract Infection of the Ferret by 2009 H1N1 Pandemic Influenza A Virus Triggers Biphasic, Systemic, and Local Recruitment of Neutrophils. |
| Q47409367 | Lymphocyte-independent pathways underlie the pathogenesis of murine cytomegalovirus-associated secondary hemophagocytic lymphohistiocytosis. |
| Q38953303 | Lymphotoxin in physiology of lymphoid tissues - Implication for antiviral defense |
| Q60302438 | MMI-0100 ameliorates lung inflammation in a mouse model of acute respiratory distress syndrome by reducing endothelial expression of ICAM-1 |
| Q39327655 | Mammalian innate resistance to highly pathogenic avian influenza H5N1 virus infection is mediated through reduced proinflammation and infectious virus release |
| Q64247882 | Manipulating the Interferon Signaling Pathway: Implications for HIV Infection |
| Q37640926 | Mapping the innate signaling cascade essential for cytokine storm during influenza virus infection |
| Q30375297 | Mast cells and influenza a virus: association with allergic responses and beyond. |
| Q61456226 | Matrix metalloproteinase-9 deficiency protects mice from severe influenza A viral infection |
| Q97536385 | Mesenchymal Stem Cell Derived Exosomes: a Nano Platform for Therapeutics and Drug Delivery in Combating COVID-19 |
| Q45326112 | MicroRNA-302a suppresses influenza A virus-stimulated interferon regulatory factor-5 expression and cytokine storm induction |
| Q99608969 | MicroRNA-4485 ameliorates severe influenza pneumonia via inhibition of the STAT3/PI3K/AKT signaling pathway |
| Q38083320 | Microbes and mucosal immune responses in asthma. |
| Q96225925 | Mitigating Coronavirus-Induced Acute Respiratory Distress Syndrome by Radiotherapy |
| Q40499866 | Modulating sphingosine 1-phosphate signaling with DOP or FTY720 alleviates vascular and immune defects in mouse sepsis |
| Q26800158 | Modulating the Innate Immune Response to Influenza A Virus: Potential Therapeutic Use of Anti-Inflammatory Drugs |
| Q30359683 | Modulation of innate immune responses by influenza-specific ovine polyclonal antibodies used for prophylaxis. |
| Q30380274 | Molecular pathogenesis of H5 highly pathogenic avian influenza: the role of the haemagglutinin cleavage site motif |
| Q30425733 | Myocarditis Associated with Influenza A H1N1pdm2009 |
| Q64040219 | National prescription for drug development |
| Q38400762 | New fronts emerge in the influenza cytokine storm |
| Q36514344 | Novel cellular targets of AhR underlie alterations in neutrophilic inflammation and inducible nitric oxide synthase expression during influenza virus infection |
| Q38138015 | Novel concepts of acute lung injury and alveolar-capillary barrier dysfunction |
| Q28084039 | Novel therapies for the treatment of pertussis disease |
| Q34663971 | Nox1 oxidase suppresses influenza a virus-induced lung inflammation and oxidative stress. |
| Q53688637 | Oncolytic influenza virus infection restores immunocompetence of lung tumor-associated alveolar macrophages. |
| Q34020489 | PI3K/Akt signaling pathway modulates influenza virus induced mouse alveolar macrophage polarization to M1/M2b |
| Q91760664 | PPAR-γ in Macrophages Limits Pulmonary Inflammation and Promotes Host Recovery following Respiratory Viral Infection |
| Q30356527 | Pandemic H1N1 influenza A directly induces a robust and acute inflammatory gene signature in primary human bronchial epithelial cells downstream of membrane fusion. |
| Q30367936 | Passive broad-spectrum influenza immunoprophylaxis |
| Q91219173 | Pathogen interactions with endothelial cells and the induction of innate and adaptive immunity |
| Q38145284 | Pathogenesis of Staphylococcus aureus necrotizing pneumonia: the role of PVL and an influenza coinfection. |
| Q38163209 | Pathogenesis of influenza-induced acute respiratory distress syndrome. |
| Q39279748 | Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology |
| Q33663298 | Pathogenic potential of interferon αβ in acute influenza infection |
| Q33907800 | Persistence in Temporary Lung Niches: A Survival Strategy of Lung-Resident Memory CD8+ T Cells |
| Q37980790 | Perspectives on immunomodulation early in life. |
| Q36396894 | Pertussis toxin exacerbates and prolongs airway inflammatory responses during Bordetella pertussis infection |
| Q30427707 | Plasmin-mediated activation of pandemic H1N1 influenza virus hemagglutinin is independent of the viral neuraminidase. |
| Q27335814 | Plasminogen controls inflammation and pathogenesis of influenza virus infections via fibrinolysis |
| Q41494592 | Platelet activation and aggregation promote lung inflammation and influenza virus pathogenesis. |
| Q36897267 | Platelets in lung biology. |
| Q39260894 | Pleiotropic Roles of Type 1 Interferons in Antiviral Immune Responses |
| Q34149169 | Pneumolysin expression by streptococcus pneumoniae protects colonized mice from influenza virus-induced disease |
| Q38794279 | Ponesimod, a selective sphingosine 1-phosphate (S1P1) receptor modulator for autoimmune diseases: review of clinical pharmacokinetics and drug disposition |
| Q30396997 | Porcine mast cells infected with H1N1 influenza virus release histamine and inflammatory cytokines and chemokines |
| Q34296984 | Postinfection A77-1726 treatment improves cardiopulmonary function in H1N1 influenza-infected mice |
| Q92126815 | Pro-inflammatory effects of crystalline- and nano-sized non-crystalline silica particles in a 3D alveolar model |
| Q36692911 | Profile of Michael B. A. Oldstone. Interview by Nicholette Zeliadt |
| Q42291845 | Progression of type 1 diabetes from the prediabetic stage is controlled by interferon-α signaling |
| Q36192895 | Prospective multicenter study of children with bronchiolitis requiring mechanical ventilation |
| Q37638594 | Protection of ferrets from pulmonary injury due to H1N1 2009 influenza virus infection: immunopathology tractable by sphingosine-1-phosphate 1 receptor agonist therapy |
| Q27324763 | Protective immunity and safety of a genetically modified influenza virus vaccine |
| Q35120982 | Protein unfolding allows use of commercial antibodies in an apolipoprotein M sandwich ELISA. |
| Q97418921 | Pulmonary endothelium-derived PD-L1 induced by the H9N2 avian influenza virus inhibits the immune response of T cells |
| Q98657516 | Pulmonary intravascular coagulopathy in COVID-19 pneumonia |
| Q38927608 | Qiangzhi decoction protects mice from influenza A pneumonia through inhibition of inflammatory cytokine storm |
| Q30419007 | Recent insights into pulmonary repair following virus-induced inflammation of the respiratory tract |
| Q39213750 | Reduction of Pertussis Inflammatory Pathology by Therapeutic Treatment With Sphingosine-1-Phosphate Receptor Ligands by a Pertussis Toxin-Insensitive Mechanism |
| Q38271831 | Reductive stress after exercise: The issue of redox individuality |
| Q37528740 | Respiratory Antiviral Immunity and Immunobiotics: Beneficial Effects on Inflammation-Coagulation Interaction during Influenza Virus Infection |
| Q64946198 | Risk assessment of the tropism & pathogenesis of the highly pathogenic avian influenza A/H7N9 virus using ex vivo & in vitro cultures of human respiratory tract. |
| Q91710092 | Role of Endothelial Cells in the Pathogenesis of Influenza in Humans |
| Q40275323 | Roles for endothelial cells in dengue virus infection |
| Q38314882 | S1P signaling: new therapies and opportunities |
| Q89655256 | S1PR1-Associated Molecular Signature Predicts Survival in Patients with Sepsis |
| Q36563415 | S1PR1-mediated IFNAR1 degradation modulates plasmacytoid dendritic cell interferon-α autoamplification |
| Q107377123 | SARS-CoV-2 Spike Protein Induces Degradation of Junctional Proteins That Maintain Endothelial Barrier Integrity |
| Q102058341 | Safety biomarkers for development of vaccines and biologics: Report from the safety biomarkers symposium held on November 28-29, 2017, Marcy l'Etoile, France |
| Q92130869 | Seasonal and pandemic influenza: 100 years of progress, still much to learn |
| Q91606909 | Serum sphingosine-1-phosphate levels and Sphingosine-1-Phosphate gene polymorphisms in acute respiratory distress syndrome: a multicenter prospective study |
| Q38256290 | Sexual dimorphism in immunity: improving our understanding of vaccine immune responses in men. |
| Q33618994 | Shigella flexneri Inhibits Intestinal Inflammation by Modulation of Host Sphingosine-1-Phosphate in Mice |
| Q40863253 | Small airway-on-a-chip enables analysis of human lung inflammation and drug responses in vitro |
| Q42314994 | Special focus: endothelial activation/dysfunction |
| Q35061720 | Sphingolipid metabolites in inflammatory disease |
| Q49972804 | Sphingolipids role in the regulation of inflammatory response: From leukocyte biology to bacterial infection |
| Q40165434 | Sphingosine 1-Phosphate Lyase Enhances the Activation of IKKε To Promote Type I IFN-Mediated Innate Immune Responses to Influenza A Virus Infection |
| Q39205808 | Sphingosine 1-Phosphate: A Novel Target for Lung Disorders. |
| Q36942346 | Sphingosine 1-phosphate and its carrier apolipoprotein M in human sepsis and in Escherichia coli sepsis in baboons. |
| Q36343327 | Sphingosine 1-phosphate receptor 1 (S1PR1) agonist CYM5442 inhibits expression of intracellular adhesion molecule 1 (ICAM1) in endothelial cells infected with influenza A viruses |
| Q38762603 | Sphingosine 1-phosphate receptor 1 agonists: a patent review (2013-2015). |
| Q42233131 | Sphingosine analog AAL-R promotes activation of LCMV-infected dendritic cells |
| Q38013700 | Sphingosine kinase 1 in viral infections. |
| Q35020246 | Sphingosine kinase 1 serves as a pro-viral factor by regulating viral RNA synthesis and nuclear export of viral ribonucleoprotein complex upon influenza virus infection |
| Q36812849 | Sphingosine-1-phosphate Receptor Agonism Reduces Bordetella pertussis-mediated Lung Pathology |
| Q37726630 | Sphingosine-1-phosphate receptor 1 reporter mice reveal receptor activation sites in vivo |
| Q36159649 | Staphylococcus aureus hemolysins, bi-component leukocidins, and cytolytic peptides: a redundant arsenal of membrane-damaging virulence factors? |
| Q90229721 | Stem cell-based Lung-on-Chips: The best of both worlds? |
| Q35082203 | Suppression of interferon lambda signaling by SOCS-1 results in their excessive production during influenza virus infection |
| Q55514867 | Surviving Deadly Lung Infections: Innate Host Tolerance Mechanisms in the Pulmonary System. |
| Q30354127 | Switch from protective to adverse inflammation during influenza: viral determinants and hemostasis are caught as culprits. |
| Q38920132 | Syndecan-1 Attenuates Lung Injury during Influenza Infection by Potentiating c-Met Signaling to Suppress Epithelial Apoptosis |
| Q52616757 | Syntheses and in vitro evaluation of new S1PR1 compounds and initial evaluation of a lead F-18 radiotracer in rodents. |
| Q37495044 | Systems analysis of sex differences reveals an immunosuppressive role for testosterone in the response to influenza vaccination |
| Q34364844 | Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond |
| Q40935716 | The Anatomy of a Career in Science. |
| Q91729703 | The Establishment and Validation of the Human U937 Cell Line as a Cellular Model to Screen Immunomodulatory Agents Regulating Cytokine Release Induced by Influenza Virus Infection |
| Q35672351 | The Modified JiuWei QiangHuo Decoction Alleviated Severe Lung Injury Induced by H1N1 Influenza Virus by Regulating the NF- κ B Pathway in Mice |
| Q41986585 | The Role of the Endothelium in HPS Pathogenesis and Potential Therapeutic Approaches |
| Q36473213 | The S1P1 receptor-selective agonist CYM-5442 reduces the severity of acute GVHD by inhibiting macrophage recruitment |
| Q89879735 | The Utility of Human Immune System Mice for High-Containment Viral Hemorrhagic Fever Research |
| Q84693193 | The acute respiratory distress syndrome |
| Q38161762 | The amazing innate immune response to influenza A virus infection |
| Q37192137 | The battle between influenza and the innate immune response in the human respiratory tract |
| Q37562976 | The complex link between influenza and severe sepsis |
| Q36459143 | The cytokine storm of severe influenza and development of immunomodulatory therapy |
| Q26766467 | The host immune response in respiratory virus infection: balancing virus clearance and immunopathology. |
| Q38981754 | The inflammatory response triggered by Influenza virus: a two edged sword. |
| Q38204270 | The organization of the sphingosine 1-phosphate signaling system |
| Q34568601 | The pathological effects of CCR2+ inflammatory monocytes are amplified by an IFNAR1-triggered chemokine feedback loop in highly pathogenic influenza infection |
| Q38044667 | The price of immunity |
| Q38770657 | The pulmonary endothelium in acute respiratory distress syndrome: insights and therapeutic opportunities |
| Q38124035 | The role of sphingosine 1-phosphate in immunity and sepsis |
| Q26862336 | The role of sphingosine-1-phosphate in endothelial barrier function |
| Q108833939 | The roles of lipids in SARS-CoV-2 viral replication and the host immune response |
| Q27335925 | Three phases of CD8 T cell response in the lung following H1N1 influenza infection and sphingosine 1 phosphate agonist therapy |
| Q33583784 | Timed action of IL-27 protects from immunopathology while preserving defense in influenza |
| Q41088947 | Transcriptional response of human umbilical vein endothelial cell to H9N2 influenza virus infection. |
| Q57158941 | Treating Influenza Infection, From Now and Into the Future |
| Q28076034 | Treating the host response to emerging virus diseases: lessons learned from sepsis, pneumonia, influenza and Ebola |
| Q30224656 | Two years after pandemic influenza A/2009/H1N1: what have we learned? |
| Q30275794 | Type I IFN signaling facilitates the development of IL-10-producing effector CD8+ T cells during murine influenza virus infection |
| Q36767643 | Type I interferons in viral control and immune regulation |
| Q37194990 | VEGF controls lung Th2 inflammation via the miR-1-Mpl (myeloproliferative leukemia virus oncogene)-P-selectin axis. |
| Q36806259 | Vascular leak is a central feature in the pathogenesis of systemic sclerosis |
| Q30352743 | Viral pathogens and acute lung injury: investigations inspired by the SARS epidemic and the 2009 H1N1 influenza pandemic |
| Q36825383 | Virus infections in the nervous system |
| Q34388874 | Virus interactions with endothelial cell receptors: implications for viral pathogenesis |
| Q40039875 | Vγ4+γδT Cells Aggravate Severe H1N1 Influenza Virus Infection-Induced Acute Pulmonary Immunopathological Injury via Secreting Interleukin-17A. |
| Q42198362 | p38MAPK, Rho/ROCK and PKC pathways are involved in influenza-induced cytoskeletal rearrangement and hyperpermeability in PMVEC via phosphorylating ERM. |
Search more.